TSNLF (Tristel) EBIT: $13.40 Mil (TTM As of Dec. 2025)


TSNLF Tristel PLC TSNLF
97 GF Score
Price $5.53
GF Value $6.13
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Tristel EBIT?

Tristel TSNLF +6.35% 97 EBIT is $13.40 Mil as of Dec. 2025. GuruFocus rates TSNLF with a GF Score™ of 97/100 and a GF Value™ of $6.13 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Tristel's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was $6.79 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was $13.40 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Tristel's annualized ROC % for the quarter that ended in Dec. 2025 was 28.34%. Tristel's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 62.36%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Tristel's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 5.63%.


Tristel  (OTCPK:TSNLF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Tristel's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=13.444 * ( 1 - 20.24% )/( (39.713 + 35.953)/ 2 )
=10.7229344/37.833
=28.34 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Tristel's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=13.588/( ( (12.19 + max(9.233, 0)) + (11.689 + max(10.47, 0)) )/ 2 )
=13.588/( ( 21.423 + 22.159 )/ 2 )
=13.588/21.791
=62.36 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8.722 + 6.299 + 2.525) - (4.372 + 0 + 3.941)
=9.233

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(11.309 + 5.784 + 0.456) - (7.079 + 0 + 0)
=10.47

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Tristel's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=13.403/238.013
=5.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tristel EBIT Related Terms


Tristel EBIT Historical Data

* Premium members only.

The historical data trend for Tristel's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tristel EBIT Chart

Tristel Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.55 2.16 6.68 9.29 11.77

Tristel Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.44 4.83 4.81 6.61 6.79

TSNLF vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Tristel's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tristel EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tristel's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Tristel's EV-to-EBIT falls into.


TSNLF
97GF Score
Tristel PLC TSNLF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tristel EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $13.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $13.40 Mil mean?
Tristel (TSNLF) has a EBIT of $13.40 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Tristel.
Is Tristel's EBIT too high?
Tristel's current EBIT is $13.40 Mil. Overall, Tristel has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tristel's EBIT compare to ISRG and BDX?
Tristel's EBIT of $13.40 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Tristel. Tristel's current EBIT is $13.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tristel stock overvalued right now?
Based on GuruFocus' analysis, Tristel (TSNLF) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.13, compared to a current price of $5.53 — trading 9.8% below its estimated fair value. The current EBIT is $13.40 Mil. Tristel's overall GF Score™ is 97/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Tristel (TSNLF), the current EBIT is $13.40 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tristel (TSNLF) Overvalued in 2026?

Based on GuruFocus' analysis, Tristel stock appears to be undervalued. The current stock price of $5.53 is trading 9.8% below its estimated GF Value™ of $6.13. GuruFocus considers Tristel to be Modestly Undervalued.

Key valuation signals for TSNLF:

  • EBIT: $13.40 Mil
  • GF Value™: $6.13 vs. price of $5.53 (9.8% below fair value)
  • GF Score™: 97/100 with 1 warning sign

No single metric tells the full story. See the TSNLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tristel Business Description

Other Exchanges TSTL:UKR1V:Germany
Address Fordham Road, Unit 1B, Lynx Business Park, Newmarket, Snailwell, Cambridgeshire, GBR, CB8 7NY
Tristel PLC's business is the sale to hospitals of its proprietary chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand and for the sporicidal disinfection of environmental surfaces under the Cache brand. Its operating segments include hospital medical device decontamination products used predominantly for infection control in hospitals; the manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates the majority of its revenue from hospital medical device decontamination and operates geographically in the UK and overseas markets.
97GF Score

Get the complete analysis for TSNLF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.53
Price
$6.13
GF Value